| Record ID | marc_columbia/Columbia-extract-20221130-019.mrc:107630665:1054 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-019.mrc:107630665:1054?format=raw |
LEADER: 01054cam a2200337Ia 4500
001 9349508
005 20130618000522.0
008 111014s2012 enka b 001 0 eng d
015 $aGBB1C0907$2bnb
016 7 $a015951273$2Uk
020 $a9780199697656 (pbk.)
020 $a0199697655 (pbk.)
035 $a(OCoLC)ocn757930900
035 $a(OCoLC)757930900
035 $a(NNC)9349508
040 $aUKMGB$cUKMGB$dYDXCP$dCDX$dUAB$dNNC-M
082 04 $a616.90461$223
090 4 $aRM267$bA55 2012
245 00 $aAntimicrobial chemotherapy /$cRoger Finch ... [et al.].
250 $a6th ed.
260 $aOxford :$bOxford University Press,$c2012.
300 $avi, 399 p. :$bill. ;$c25 cm.
500 $aPrevious ed.: 2007.
504 $aIncludes bibliographical references and index.
650 0 $aAnti-infective agents.
650 0 $aCommunicable diseases$xChemotherapy.
650 12 $aAnti-Infective Agents.
650 22 $aCommunicable Diseases.
650 22 $aDrug Therapy.
700 1 $aFinch, R. G.$q(Roger G.)
852 00 $boff,hsl$hRM267$i.A55 2012